Objectives To perform a systematic literature review (SLR) informing the 2016 update of the
recommendations for the management of rheumatoid arthritis (RA). Methods An SLR for the …

Objectives: Development of therapies for systemic lupus erythematosus (SLE) has in part
been limited by the lack of suitable outcome measures in clinical trials. In the present post …

Objective: To determine the prevalence of adverse health-related quality of life (HRQoL)
outcomes in patients with SLE who achieved an adequate clinical response after a 52-week …

Objectives To investigate the impact of remission and lupus low disease activity state
(LLDAS) on health-related quality of life (HRQoL) in systemic lupus erythematosus. Methods …

Objectives To identify predictors of low disease activity and clinical remission following
belimumab treatment in SLE. Methods SLE patients who received belimumab 10 mg/kg (N …

Objectives Associations between BMI and health-related quality of life (HRQoL) in SLE have
been implied, but data are scarce. We determined the impact of overweight and obesity on …

Objective To determine whether an induction-maintenance strategy of combined therapy
(methotrexate (MTX)+ tumour necrosis factor (TNF) inhibitor (TNFi)) followed by withdrawal …

Objectives: To investigate whether self-reported EQ-5D full health state (FHS) after
therapeutic intervention for active systemic lupus erythematosus (SLE) is associated with a …

Summary Background The Definitions Of Remission In Systemic Lupus Erythematosus
(DORIS) international task force has proposed remission definitions that are amenable to …

Medication non-adherence is common among patients with systemic lupus erythematosus
(SLE) and may lead to poor clinical outcomes. Our aim was to identify influenceable …